The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer (Q41785872)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 September 2013
edit
Language Label Description Also known as
English
The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
scientific article published on 24 September 2013

    Statements

    The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer (English)
    24 September 2013
    e25997

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit